Palladin, Cytoskeletal Associated Protein (PALLD) (N-Term) Peptid
PALLD
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5513514
Kurzübersicht für Palladin, Cytoskeletal Associated Protein (PALLD) (N-Term) Peptid (ABIN5513514)
Target
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- HQRKGGPQSQ LCDKAANLIE ELTSIFKAAK PRNRSPNGES SSPDSGYLSP
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PALLD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Hintergrund
-
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alias Symbols: PALLD,KIAA0992,CGI-151,
Protein Size: 1383 -
Gen-ID
- 23022
-
NCBI Accession
- XP_005262919
-
UniProt
- Q8WX93
Target
-
Sie sind hier:
